Follow
Joke Bilcke
Joke Bilcke
Center for Health Economics Research and Modeling of Infectious Diseases, University of Antwerp
Verified email at uantwerp.be
Title
Cited by
Cited by
Year
Rotavirus disease and vaccination: impact on genotype diversity
J Matthijnssens, J Bilcke, M Ciarlet, V Martella, K Bányai, M Rahman, ...
Future microbiology 4 (10), 1303-1316, 2009
3582009
Lessons from a decade of individual-based models for infectious disease transmission: a systematic review (2006-2015)
L Willem, F Verelst, J Bilcke, N Hens, P Beutels
BMC infectious diseases 17, 1-16, 2017
1912017
Accounting for methodological, structural, and parameter uncertainty in decision-analytic models: a practical guide
J Bilcke, P Beutels, M Brisson, M Jit
Medical Decision Making 31 (4), 675-692, 2011
1812011
Cost of respiratory syncytial virus-associated acute lower respiratory infection management in young children at the regional and global level: a systematic review and meta …
S Zhang, LZ Akmar, F Bailey, BA Rath, M Alchikh, B Schweiger, ...
The Journal of infectious diseases 222 (Supplement_7), S680-S687, 2020
1552020
Biomass production efficiency controlled by management in temperate and boreal ecosystems
M Campioli, S Vicca, S Luyssaert, J Bilcke, E Ceschia, FS Chapin III, ...
Nature geoscience 8 (11), 843-846, 2015
1552015
Methods for health economic evaluation of vaccines and immunization decision frameworks: a consensus framework from a European vaccine economics community
B Ultsch, O Damm, P Beutels, J Bilcke, B Brüggenjürgen, A Gerber-Grote, ...
Pharmacoeconomics 34, 227-244, 2016
1272016
The cost-effectiveness of rotavirus vaccination: Comparative analyses for five European countries and transferability in Europe
M Jit, J Bilcke, MJJ Mangen, H Salo, H Melliez, WJ Edmunds, Y Yazdan, ...
Vaccine 27 (44), 6121-6128, 2009
1142009
Detection of human papillomavirus DNA in urine. A review of the literature
A Vorsters, I Micalessi, J Bilcke, M Ieven, J Bogers, P Van Damme
European journal of clinical microbiology & infectious diseases 31, 627-640, 2012
1132012
The cost-effectiveness of varicella and combined varicella and herpes zoster vaccination programmes in the United Kingdom
AJ Van Hoek, A Melegaro, N Gay, J Bilcke, WJ Edmunds
Vaccine 30 (6), 1225-1234, 2012
852012
Health and economic burden of respiratory syncytial virus (RSV) disease and the cost-effectiveness of potential interventions against RSV among children under 5 years in 72 …
X Li, L Willem, M Antillon, J Bilcke, M Jit, P Beutels
BMC medicine 18, 1-16, 2020
822020
Cost-effectiveness of routine and campaign use of typhoid Vi-conjugate vaccine in Gavi-eligible countries: a modelling study
J Bilcke, M Antillón, Z Pieters, E Kuylen, L Abboud, KM Neuzil, AJ Pollard, ...
The Lancet Infectious Diseases 19 (7), 728-739, 2019
802019
The health and economic burden of chickenpox and herpes zoster in Belgium
J Bilcke, B OGUNJIMI, C Marais, F De Smet, M Callens, K Callaert, ...
Epidemiology & Infection 140 (11), 2096-2109, 2012
732012
Cost-Effectiveness of Rotavirus Vaccination: Exploring Caregiver (s) and``No Medical Care''Disease Impact in Belgium
J Bilcke, P Van Damme, P Beutels
Medical Decision Making 29 (1), 33-50, 2009
732009
Influenza-like-illness and clinically diagnosed flu: disease burden, costs and quality of life for patients seeking ambulatory care or no professional care at all
J Bilcke, S Coenen, P Beutels
PloS one 9 (7), e102634, 2014
712014
Reviewing the cost effectiveness of rotavirus vaccination: the importance of uncertainty in the choice of data sources
J Bilcke, P Beutels
Pharmacoeconomics 27, 281-297, 2009
702009
Sustained low rotavirus activity and hospitalisation rates in the post-vaccination era in Belgium, 2007 to 2014
M Sabbe, N Berger, A Blommaert, B Ogunjimi, T Grammens, M Callens, ...
Eurosurveillance 21 (27), 30273, 2016
642016
Estimating the incidence of symptomatic rotavirus infections: a systematic review and meta-analysis
J Bilcke, P Van Damme, M Van Ranst, N Hens, M Aerts, P Beutels
PloS one 4 (6), e6060, 2009
622009
Cost-effectiveness analysis of typhoid conjugate vaccines in five endemic low-and middle-income settings
M Antillón, J Bilcke, AD Paltiel, VE Pitzer
Vaccine 35 (27), 3506-3514, 2017
612017
Childhood varicella-zoster virus vaccination in Belgium: cost-effective only in the long run or without exogenous boosting?
J Bilcke, A Jan van Hoek, P Beutels
Human vaccines & immunotherapeutics 9 (4), 812-822, 2013
562013
Did large-scale vaccination drive changes in the circulating rotavirus population in Belgium?
VE Pitzer, J Bilcke, E Heylen, FW Crawford, M Callens, F De Smet, ...
Scientific reports 5 (1), 18585, 2015
532015
The system can't perform the operation now. Try again later.
Articles 1–20